Florida cautions against prescribing psychiatric drugs to children for depression, anxiety

The Florida Department of Health has issued new guidance regarding the use of psychotropic medications for children and adolescents between the ages of 5 and 17. The state now recommends against the use of these drugs as a primary treatment for conditions such as depression, anxiety, and attention-deficit disorders. Officials suggest that clinicians prioritize psychotherapy and other behavioral management strategies over chemical interventions in most cases.

State Surgeon General Dr. Joseph A. Ladapo stated that treatment decisions must rely on a specific understanding of each child’s health circumstances. He emphasized that parents require clear information about risks and potential alternatives to make informed choices for their families. This directive aligns with broader discussions regarding the frequency of psychiatric medication use among young people.

This move mirrors goals recently discussed by federal health officials within the Make America Healthy Again initiative. The guidance stresses that medications should not function as a substitute for individual therapy. While state officials maintain that these drugs have a role when clinically necessary, they are pushing for more rigorous assessments before any prescription is issued.

Medical organizations, including the American Academy of Child and Adolescent Psychiatry, have previously expressed caution about state-led efforts that challenge established clinical standards. They argue that decisions regarding mental health services should remain grounded in evidence provided by child psychiatrists. The Florida Department of Health maintains that its guidance is designed to encourage comprehensive patient assessment rather than to contradict medical standards.